Ajay Saxena

Selective IRAK4 Inhibition Attenuates Disease in Murine Lupus Models and Demonstrates Steroid Sparing Activity

Shailesh Dudhgaonkar, Sourabh Ranade, Jignesh Nagar et al. · The Journal of Immunology · 2016 · 74 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Lipophilic salts of poorly soluble compounds to enable high-dose lipidic SEDDS formulations in drug discovery

Michael M. Morgen, Ajay Saxena, Xueqing Chen et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2017 · 54 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Bioequivalence Comparison of Pediatric Dasatinib Formulations and Elucidation of Absorption Mechanisms Through Integrated PBPK Modeling

Shruthi Vaidhyanathan, Xiaoning Wang, John R. Crison et al. · Journal of Pharmaceutical Sciences · 2018 · 44 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Selective <i>I</i>_Kur Inhibitors for the Potential Treatment of Atrial Fibrillation: Optimization of the Phenyl Quinazoline Series Leading to Clinical Candidate 5-[5-Phenyl-4-(pyridin-2-ylmethylamino)quinazolin-2-yl]pyridine-3-sulfonamide

Prashantha Gunaga, John Lloyd, Somanadham Mummadi et al. · Journal of Medicinal Chemistry · 2017 · 25 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Prediction of pH dependent absorption using in vitro, in silico, and in vivo rat models: Early liability assessment during lead optimization

Ajay Saxena, Devang Shah, Shweta Padmanabhan et al. · European Journal of Pharmaceutical Sciences · 2015 · 21 citations

Pharmacy, Pharmacology, Physiology +15